Life science experts

Perfecting
Biology

We design synthetic signalling molecules for more reliable cell culture and biomanufacturing.

Life Science experts

Combining cell biology, biophysics and AI to design
synthetic signals for more predictable biology.

Biological signals

  • Direct how cells survive, grow and change
  • Are essential to cell culture
  • Can introduce variability into research
    and manufacturing
A living cell studded with surface receptors, molecules approaching

Biological inputs were not designed for modern manufacturing

Growing and directing cells depends on complex biological signals. Variability in those inputs can affect experimental reproducibility, process control and scale-up.

Where variability becomes process risk

  • A cleanroom production suite with closed bioreactors and fluid-handling lines
    01

    Consistency

    Changing inputs can produce changing cellular responses.

  • Researchers working with cell cultures in a life-science laboratory
    02

    Stability

    Activity can drift under demanding culture conditions.

  • A modern biomanufacturing facility with stainless-steel bioreactors
    03

    Quality

    Complex inputs add characterisation and control burdens.

  • A stirred bioreactor beside cell-culture monitoring equipment
    04

    Scale

    Inputs suitable for discovery do not always translate cleanly to production.

When the input changes, the biology can change with it.

The Problem
Biological variability Process risk

Small changes in a culture input can propagate through an
entire experiment or manufacturing run.

  • Signal strength can change how cells survive, grow and differentiate.
  • Activity can decline during culture, shifting the effective signal over time.
  • Complex biological production adds impurities, controls and validation work.
Immunofluorescence of an early endoderm differentiation: nuclei labelled for OCT4, EOMES and Brachyury

Cell culture depends on precise signals.
Variable inputs undermine that precision.

The Solution

Purpose-built synthetic molecules
for cell culture and biomanufacturing.

Designed to reproduce essential biological signals in a defined, manufacturable form.

  1. 01

    Designed for consistency

    A defined molecular input with measurable properties.

  2. 02

    Built for stability

    Performance considered under real culture conditions.

  3. 03

    Made with scale in mind

    Manufacturability considered from the beginning.

A manufacturing input,
not a therapy.

De novo design Each molecule is designed around a defined biological objective.
The Process

From computational design to evidence in living cells

We have built the design engine. This is what we do with it.

01 Design

We use our own platform to turn a biological objective into candidates worth testing.

02 Validate

We synthesise selected candidates and measure their behaviour in relevant experimental systems.

03 Translate

We work with research and manufacturing partners to translate validated molecules into useful biological processes.

Inside the design step

A flexible workspace, guided by scientists

Our platform brings the computational work into one traceable environment, helping us move from a defined objective to a focused set of candidates.

The Optima design canvas showing a branching molecular-design workflow beside a three-dimensional structure viewer
A branching design workflow with a candidate open in the structure viewer.
  1. 01

    Frame the objective

    Define the target, the biological evidence and the practical constraints.

  2. 02

    Explore and compare

    Combine complementary methods, review alternatives and refine promising branches.

  3. 03

    Select with evidence

    Record each decision and advance only the candidates that meet the programme criteria.

Every design ends
in living cells.
Team

Three disciplines. One founding team.

Optima brings together biological product strategy, experimental validation and research partnerships, and the experience to build and operate an early-stage company.

Biological product strategy

Cell biologyMolecular designProduct direction

More than twenty years of scientific R&D across academia and biotech underpin the company's technical and strategic direction, from the initial platform architecture and molecular design work through to product definition.

  • PhD in cell and molecular biology; BSc biochemistry
  • R&D experience across academia and biotechnology
  • Platform architecture, molecular design and product definition
  • Machine learning and AI certification, University of Cambridge

Experimental validation and partnerships

Molecular biophysicsDe-riskingResearch partnerships

More than twenty years in academic and industrial R&D, including early-stage drug discovery, shape our experimental validation strategy: rigorous de-risking and research partnerships with leading academic and commercial laboratories.

  • Molecular biophysics, structural biology and immunology
  • More than four years supporting UK and US start-ups in early-stage drug discovery
  • Research posts at Oxford, Cambridge, Bristol and Johns Hopkins
  • DPhil, University of Oxford; BSc (Hons) Physics, University of Edinburgh; Cambridge EnterpriseTECH

Building and running the company

Company buildingOperationsEarly-stage investment

Twenty-seven years in UK technology, fourteen of them founding and running profitable businesses, alongside CTO and director roles across several start-ups. Experience on both sides of the investment table informs what an early company must prove, and in what order.

  • Founder and operator of profitable technology businesses
  • CTO and director roles across multiple start-ups
  • Investor in 92 early-stage companies
  • London Business School MBA; University of Cambridge BA
3founding team members with complementary expertise
40+combined years of scientific R&D
27years in UK technology businesses

Scientific judgement, experimental rigour and company-building experience — brought together from day one.

Get in touch

Let’s talk.

Interested in Optima Biolabs? We welcome conversations with investors, scientists and potential partners.

Write to us at contact@optimabiolabs.com

Investor information

Investor deck

Share your details and we’ll email you the deck once approved.

Investor information

Request our investor deck

Enter your details and we’ll review your request. Once approved, we’ll email a personal download link to your work address.

We use these details to review your request, email you the deck if approved and, where appropriate, follow up about your request. Request records are retained for up to 24 months. If you opt in to updates, we retain your contact details until you unsubscribe.